Cardiac Injury after survived SARS-CoV2-infection (COVID19)

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00023831
• Lead Sponsor: Franzen Institut

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-06
• Study Completion: 2021-12-31
• Results First Posted: 2022-09-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

Age 18-80 years, signed informed consent, 1st SARS-CoV2-Infection (COVID19) confirmed with PCR from nasal and throat swab

Exclusion Criteria

Age < 18 years or > 80 years, no informed consent, ESKD, dementia, patient with myocarditis/brain infarction/myocardial infarction/cardiac surgery/pacemaker-implantation in the medical history, Patients after heart transplant, congenital heart diseases, re-infection with SARS-CoV2

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Global ECG- and echocardiographic changes after 3 and 6 months

Secondary Outcome Measures

Name	Time	Method
Persisting repolarization disorders, persisting depolarization disorders, LV-Dysfunction, Myokarditis